Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.48 USD | -0.67% | +2.07% | +2.07% |
Mar. 12 | Rigel Pharmaceuticals Announces Appointment of Lisa Rojkjaer as Chief Medical Officer | CI |
Mar. 07 | Citigroup Adjusts Rigel Pharmaceuticals' Price Target to $4 From $3, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.07% | 260M | |
+2.73% | 108B | |
+9.59% | 103B | |
+6.58% | 23.48B | |
-12.59% | 21.93B | |
-3.29% | 19.68B | |
-35.36% | 18.37B | |
-13.29% | 16.33B | |
+4.68% | 13.72B | |
+34.25% | 12.15B |
- Stock
- Equities
- Stock Rigel Pharmaceuticals, Inc. - Nasdaq
- News Rigel Pharmaceuticals, Inc.
- Rigel Pharmaceuticals Launches Rezlidhia in US for Relapsed/Refractory Acute Myeloid Leukemia